Similar to IL‐37 treatment, administration of a single injection of IL‐37 plus TnI–treated tDCs in post‐MI mice significantly reduced the infiltration of inflammatory cells, ameliorated myocardial fibrosis, and improved cardiac function. This evidence concerns the gene IL37 and myocardial infarction.